A COVID-19 Diagnosis Like an Avalanche Triggers a Series of Adverse Events but Saves a Life in the End.

COVID-19 cancer oncologic therapy thrombotic complications

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
26 Jun 2023
Historique:
received: 19 05 2023
revised: 20 06 2023
accepted: 21 06 2023
medline: 14 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Patients diagnosed with cancer are less frequently covered by preventive measures for cardiovascular diseases. The frequent co-occurrence of these diseases makes it necessary to apply parallel diagnostics and cardiological treatment with anti-cancer therapy. Frequently. multidisciplinary team discussions are needed. Case report: We present a case of a 73-year-old former smoker with hyperlipidemia, type 2 diabetes, and arterial hypertension, after a partial right nephrectomy in 2005 due to kidney cancer, diagnosed with SARS-CoV-2 infection in April 2022. Subsequent chest imaging showed a 20 mm focal lesion in the left lung further classified as a small-cell neuroendocrine carcinoma. Unexpectedly, the patient was hospitalized due to ST-segment elevation inferior left ventricular (LV) myocardial infarction. It was treated successfully with percutaneous coronary angioplasty (PCI) of the circumflex and first marginal artery with drug-eluting stent (DES) implantation. One day later, PCI of the left anterior artery was performed with two DES implantation; however, heart failure (HF) with a reduced left ventricle ejection fraction of 30% was diagnosed. One month later, the patient required hospitalization again due to HF decompensation, and cardiological treatment was optimized with flozin in addition to standard HF therapy. Subsequently, after cardiological approval the patient qualified for chemotherapy with the cisplatin-etoposide regimen. Therapy was continued for 6 months without HF decompensation and significant deterioration in renal function. After that, the patient underwent radical radiotherapy. Follow-up chest computed tomography scans showed regression of the neoplastic lesion. Conclusions: The coincidence of newly recognized cancer and inflammatory disease might contribute to and provoke serious cardiological events. To reduce the risk of cardiovascular complications, periodic cardiological surveillance and optimal pharmacotherapy are required.

Identifiants

pubmed: 37444681
pii: healthcare11131847
doi: 10.3390/healthcare11131847
pmc: PMC10340565
pii:
doi:

Types de publication

Case Reports

Langues

eng

Références

Cardiovasc Res. 2019 Apr 15;115(5):844-853
pubmed: 30715247
Chest. 2003 Jan;123(1):304-6
pubmed: 12527639
J Am Coll Cardiol. 2017 Aug 22;70(8):926-938
pubmed: 28818202
J Comorb. 2014 Aug 18;4:29-36
pubmed: 29090151
Eur Heart J. 2022 Nov 1;43(41):4229-4361
pubmed: 36017568
Eur Heart J. 2020 Jan 1;41(1):12-85
pubmed: 31820000
Circ Heart Fail. 2020 Jul;13(7):e007220
pubmed: 32500721
Eur J Epidemiol. 2017 Mar;32(3):193-201
pubmed: 28176141
JACC CardioOncol. 2022 Mar 15;4(1):85-94
pubmed: 35492824
JACC CardioOncol. 2023 Apr 11;5(4):431-440
pubmed: 37614573
Blood. 2020 Sep 10;136(11):1317-1329
pubmed: 32573711
J Cardiovasc Transl Res. 2020 Jun;13(3):431-450
pubmed: 32642841
Intern Med. 2022 Feb 1;61(3):345-350
pubmed: 34248120
CA Cancer J Clin. 2016 Jul;66(4):309-25
pubmed: 26919165
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
BMC Cardiovasc Disord. 2020 Nov 11;20(1):482
pubmed: 33176705
Eur J Cancer. 2013 Apr;49(6):1374-403
pubmed: 23485231
Kardiol Pol. 2022;80(7-8):869-870
pubmed: 35703431
JACC CardioOncol. 2021 Nov 16;3(5):619-634
pubmed: 34988471

Auteurs

Mateusz Iwański (M)

College for Medical Sciences, University of Rzeszow, 35-315 Rzeszow, Poland.

Aldona Sokołowska (A)

College for Medical Sciences, University of Rzeszow, 35-315 Rzeszow, Poland.

Piotr Wańczura (P)

Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, 35-111 Rzeszow, Poland.

Justyna Filipowska (J)

Subcarpathian Oncological Center, University Clinical Hospital of Frederic Chopin, 35-055 Rzeszow, Poland.

Katarzyna Styczkiewicz (K)

College for Medical Sciences, University of Rzeszow, 35-315 Rzeszow, Poland.
Subcarpathian Oncological Center, University Clinical Hospital of Frederic Chopin, 35-055 Rzeszow, Poland.

Classifications MeSH